The Emerging Promise of Pentacyclic Triterpenoid Derivatives as Novel Antiviral Agents Against SARS-CoV-2 Variants
Xin Wan, Xiaoxuan Cui, Ke Liang, Junran Huang, Kangan Chen, Wen Chen, Gaopeng Song
TL;DR
This paper explores how plant-derived compounds called pentacyclic triterpenoids may offer new antiviral treatments against SARS-CoV-2 variants, including Omicron.
Contribution
The paper systematically reviews structure–activity relationships of PTs and proposes new strategies for multi-target inhibitors against SARS-CoV-2 variants.
Findings
Pentacyclic triterpenoids inhibit multiple SARS-CoV-2 targets, including spike protein and RdRp.
These compounds show broad-spectrum activity against variants from Alpha to Omicron.
Structure–activity relationships suggest ways to design more effective multi-target inhibitors.
Abstract
The continuous emergence of SARS-CoV-2 variants, especially the Omicron strain with its heightened transmissibility, has posed ongoing challenges to the efficacy of existing vaccine and drug regimens. This situation highlights the pressing demand for antiviral drugs employing novel mechanisms of action. Pentacyclic triterpenoids (PTs), a structurally varied group of compounds derived from plants, exhibit both antiviral and anti-inflammatory activities, making them attractive candidates for further therapeutic development. These natural products, along with their saponin derivatives, show broad-spectrum inhibitory effects against multiple SARS-CoV-2 variants (from Alpha to Omicron) via interactions with multiple targets, such as the spike protein, main protease (Mpro), RNA-dependent RNA polymerase (RdRp), and inflammatory signaling pathways. This review consolidates recent findings on…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11
Figure 12
Figure 13
Figure 14Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNatural product bioactivities and synthesis · Pharmacological Effects of Natural Compounds · Traditional Chinese Medicine Analysis